Home/Filings/4/0001447028-23-000076
4//SEC Filing

Rewolinski Melissa 4

Accession 0001447028-23-000076

CIK 0001447028other

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 4:13 PM ET

Size

5.6 KB

Accession

0001447028-23-000076

Insider Transaction Report

Form 4
Period: 2023-07-12
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-12+110,000110,000 total
    Exercise: $2.27Exp: 2033-07-12Common Shares (110,000 underlying)
Footnotes (2)
  • [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on July 12, 2023, the date of the grant.
  • [F2]The option will vest and become exercisable in three equal annual installments beginning one year from the grant date.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001780206

Filing Metadata

Form type
4
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 4:13 PM ET
Size
5.6 KB